Biological sciences researchers from the U of A have led the publication of a paper that expands our understanding of sensory ...
Johns Hopkins scientists develop mRNA "booster" as potential new way to treat rare genetic diseases marked by too low levels ...
Bionexus Gene Lab Corporation was the first Nasdaq-listed company Ethereum (ETH) to Bitcoin (BTC) chosen as strategic ...
BioNexus Gene Lab (BGLC) announced a strategic partnership with ML Tech to optimize the BGLC’s Ethereum-based growth ...
BioNexus Gene Lab Corp. (NASDAQ: BGLC), a technology company dedicated to innovation in the digital and healthcare space, has announced a strategic partnership with ML Tech to optimize the BGLC’s ...
Ethereum ETF flows have shown volatility, signaling uncertainty for ETH's short-term recovery. Despite institutional interest ...
Additionally, BioNexus sees Ethereum’s deep integration in the global financial ecosystem as a key factor. The Ethereum ...
Ethereum’s bullish momentum continues, driven by the Pectra upgrade and BioNexus announcement, pushing ETH towards a ...
Ethereum has been chosen over Bitcoin as a medical firm's treasury asset. The firm cited staking, DeFi, dApps, and other ...
Ethereum [ETH] ETF flows turned positive after 10 days of an outflow trend, signaling a likely renewed demand for the altcoin. On the 4th of March, the products logged $14.58M inflows, and marched ...
BioNexus Gene Lab board of directors has officially approved the Ethereum-focused treasury strategy, alongside an ETH ...
BioNexus Gene Lab Corporation, a leading medical laboratory services provider, has made history by becoming the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results